Home > Income Statement > INDO US BIOTECH

INDO US BIOTECH
Consolidated Net Profit

    Back to Income Statement
INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Last 5 Year Consolidated Net Profit History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021

What is the latest Consolidated Net Profit of INDO US BIOTECH ?

The latest Consolidated Net Profit ratio of INDO US BIOTECH is ₹8.11 based on Mar2025 Standalone results.
Year Consolidated Net Profit
Mar2025₹8.11
Mar2024₹4.12
Mar2023₹3.61
Mar2022₹2.86
Mar2021₹3.50

How is Consolidated Net Profit of INDO US BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹8.11
0
Mar2024 ₹4.12
0
Mar2023 ₹3.61
0
Mar2022 ₹2.86
0
Mar2021 ₹3.50 -

Compare Consolidated Net Profit of peers of INDO US BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDO US BIOTECH ₹247.2 Cr -5.9% -13.5% -52.3% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,951.9 Cr 5.7% 2.2% -29.4% Stock Analytics
KAVERI SEED COMPANY ₹5,464.9 Cr -0% -11.7% 17.1% Stock Analytics
VENKYS (INDIA) ₹2,042.1 Cr -2.1% -4.2% -22.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,277.0 Cr -1.8% -7.8% -28.8% Stock Analytics
MANGALAM GLOBAL ENTERPRISE ₹498.0 Cr -9.8% -4.8% NA Stock Analytics


INDO US BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDO US BIOTECH

-5.9%

-13.5%

-52.3%

SENSEX

1.8%

1.9%

2.4%


You may also like the below Video Courses